I have Aspen shares & believe in the shrewd management now that they have had their nose bloodied by those expensive deals they concluded with Glaxo which caused them to sell the infant milk business...Their crown jewel & money printing machine literally...
They have received some negative attention by EU regulators & selling some of the more monopolistic injectables businesses is a step back under the radar.
I feel there'll be the mild volatility until year end when the sale concludes & the cash is allocated...Hopefully entirely towards debt....Then they can re-boot focus on improving margins on existing businesses & really cementing their local knowledge & position above all others.
Should they choose to acquire something then borrow for that..
It's a solid profitable business that has a bright future & these top guys Saad & Atteridge have plenty skin in this...I'm always a buyer below R130
Have a profitable day.